Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors

Tissue Antigens

Volumn 63, Issue 5, 2004, Pages 453-457

  Corbiere V ^a   Nicolay, H ^a,b   Russo, V ^c   Stroobant, V ^a,b   Brichard, V ^d,e   Boon, T ^a,b   Van Der Bruggen, P ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e GSK   (Belgium)

Author keywords

Antigen; Cytolytic T lymphocyte; Dendritic cells; HLA B57; MAGE; Peptide; Poxvirus; Tumor

Indexed keywords

HLA B ANTIGEN; HLA B5701 ANTIGEN; MELANOMA ANTIGEN 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL; TUMOR CELL; VACCINATION;

ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; HERPESVIRUS 4, HUMAN; HLA-B ANTIGENS; HUMANS; NEOPLASM PROTEINS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

POXVIRIDAE;

EID: 2442547305     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-2815.2004.00203.x     Document Type: Article

References (27)

1. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001: 61: 5544-51.
2. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991: 254: 1643-7.
3. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 1995: 55: 3478-82.
4. Haas GG, D'Cruz OJ, De Bault LE. Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am J Reprod Immunol Microbiol 1988: 18: 47-51.
5. van der Bruggen P, Zhang Y, Chaux P et al. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 2002: 188: 51-64
6. Marchand M, van Baren N, Weynants P et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999: 80: 219-30.
7. Marchand M, Punt CJA, Aamdal S et al. Immunization of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: clinical report. Eur J Cancer 2003: 39: 70-7.
8. + melanoma patients by mature monocyte-derived dendritic cells. J Immunol 2000: 165: 3492-6.
9. Schuler-Thurner B, Schultz ES, Berger TG et al. Rapid induction of tumor-specific type I T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med 2002: 195: 1279-88.
10. Van den Eynde B, van der Bruggen P. Peptide database of T-cell defined tumor antigens. Cancer Immun 2001 (available from: http://www.cancerimmunity. org/peptidedatabase/Tcellepitopes-htm).
11. Traversari C, van der Bruggen P, Luescher IF et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992: 176: 1453-7.
12. Tanzarella S, Russo V, Lionello I et al. Identification of a promiscuous T cell epitope encoded by multiple members of the MAGE family. Cancer Res 1999: 59: 2668-74.
13. van der Bruggen P, Szikora J-P, Boël P et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol 1994: 24: 2134-40.
14. Luiten RM, Demotte N, Tine J, van der Bruggen P. A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules. Tissue Antigens 2000: 56: 77-81.
15. Fujie T, Tahara K, Tanaka F, Mori M, Takesako K, Akiyoshi T. A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes. Int J Cancer 1999: 80: 169-72.
16. Luiten R, van der Bruggen P. A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes. Tissue Antigens 2000: 55: 149-52.
17. Chaux P, Luiten R, Demotte N et al. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J Immunol 1999: 163: 2928-36.
18. Zhang Y, Stroobant V, Russo V, Boon T, van der Bruggen P. A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes. Tissue Antigens 2002: 60: 365-71.
19. Mavilio F, Ferrari G, Rossini S et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994: 83: 1988-97.
20. Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994: 180: 83-93.
21. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994: 179: 1109-18.
22. Pascolo S, Schirle M, Guckel B et al. A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. Cancer Res 2001: 61: 4072-7.
23. Traversari C, van der Bruggen P, Van den Eynde B et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992: 35: 145-52.
24. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986: 95: 99-105.
25. Barber LD, Percival L, Arnett KL, Gumperz JE, Chen L, Parham P. Polymorphism in the a1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J Immunol 1997: 158: 1660-9.
26. Gjertson DW, Terasaki PI. HLA 1998. Lenexa: American Society for Histocoinpatibility and Immunogenetics, 1998.
27. Levine JE, Yang SY. Allelic frequencies of the HLA-B17 antigen group: comparative analysis by serology, IEF and PCR-SSOP typing. Tissue Antigens 1995: 46: 368-73.